Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05499507 · ClinicalTrials.gov registry record · NA
The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
A NA study of Obesity and Hypertension, sponsored by Temple University.
- Recruiting
- Registry status
- NA
- Development phase
- 432
- Enrollment target
- 1
- Study location
NCT05499507: Recruiting NA study of Obesity and Hypertension, sponsored by Temple University.
NCT05499507 is a NA study of Obesity and Hypertension that is actively recruiting participants, run by Temple University. The registered enrollment target is 432 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05499507, a NA study of Obesity and Hypertension, is actively recruiting participants, sponsored by Temple University.
- RECRUITING
- Registry status
- NA
- Development phase
- 432 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.
Primary Outcome
Blood pressure will be measured at each time point on the upper arm three times at one-minute intervals after five minutes of quiet sitting. The investigators will use the validated Omron HEM-907XL and the appropriate size cuff. The investigators will average the three measures for analysis.
Conditions Studied
Interventions
- BEHAVIORAL COH
- BEHAVIORAL COH+
Study Locations (1)
Pennsylvania
- Temple University/Temple Health - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 432 participants |
| Start Date | 2023-01-24 |
| Est. Completion | 2028-12-10 |
| Phase | NA |
What NCT05499507 shows while recruiting
NCT05499507 is an interventional study that assigns participants to a tested intervention. The registered 432 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (47% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which COH is the first listed.
NCT05499507 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05499507 about?
NCT05499507 is a clinical study titled "The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)". The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.
What is the current status of trial NCT05499507?
This trial is currently recruiting. It is a NA study. The enrollment target is 432 participants. The study started on 2023-01-24. Estimated completion is 2028-12-10.
What conditions does trial NCT05499507 study?
This clinical trial studies the following conditions: Obesity, Hypertension, Pregnancy Related, Racism.
What interventions are being tested in trial NCT05499507?
The interventions under investigation include: COH (BEHAVIORAL), COH+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT05499507?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05499507 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05499507's enrollment target sits among peer trials
432 158th of 1053 higher than 896 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- NCT05365815 · 432 participants · NA
Melanated Group Midwifery Care (MGMC)
- NCT05806164 · 432 participants · Phase 4
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
- NCT07088406 · 432 participants · NA
A Multi-level Mother-daughter Physical Activity Intervention for Pre- Adolescent Latinas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI